Written Exposure Therapy Rivals SSRIs
For years, the treatment of Post-Traumatic Stress Disorder (PTSD) has been divided into two camps: pharmacotherapy (SSRIs) and long-term psychotherapy (CBT/Prolonged Exposure). A new large-scale pragmatic trial published in JAMA Psychiatry challenges the necessity of long-term interventions, offering rigorous data on a shorter, mechanism-focused alternative. The study compared the standard pharmacological standard of care (Sertraline/Paroxetine)…
Forest Bathing Enhances Natural Killer (NK) Cytotoxicity
Categorized under “wellness” or “lifestyle,” Forest Bathing is built on a foundation of rigorous physiological data. Originating in Japan in the 1980s as a response to a spike in stress-related cardiac events, the practice has since been subjected to extensive clinical scrutiny. The latest reviews indicate that the benefits of forest immersion are not psychological…
Reduce Depression and Systemic Inflammation in 15 Seconds
For decades, the “gold standard” of mindfulness-based stress reduction (MBSR) has required patients to commit to 20 to 45 minutes of daily practice. While effective, attrition rates remain high due to time constraints and the difficulty of sustained focus for patients with acute anxiety or depressive disorders. Now, a new study published in Scientific Reports…
AMT-130 Trial for Huntington’s Treatment Slows Progression
In a significant development for the field of neurodegenerative medicine, updated data released in late 2025 regarding the investigational gene therapy AMT-130 indicates a potential breakthrough in Huntington’s treatment. According to reports covering the ongoing Phase I/II clinical trials by biotechnology firm uniQure, the therapy has demonstrated the ability to slow disease progression by approximately…
